What researchers published on Myeloproliferative neoplasms
890 papers, newest first.
Showing 20 of 890
Case reportCase Report: Real-world experience with pacritinib after prior ruxolitinib exposure in myelofibrosis in Saudi Arabia: a report of five cases.Frontiers in medicine
Not labelled yetHematological trajectories and pregnancy complications in essential thrombocythemia and polycythemia vera.Annals of hematology
Not labelled yetEffects of calreticulin mutations on HLA class I expression in myeloproliferative neoplasms.JCI insight
ReviewSGLT2 Inhibitors and Hemoglobin Improvement in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: Mechanistic Rationale and Emerging Clinical Evidence.Anemia
ReviewArterial thrombosis redirects the natural history of myeloproliferative neoplasms: A biological perspective.Annals of hematology
Not labelled yetAssociation does not establish causation. Comment on: "Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia".Haematologica
Case report[Coronary Artery Bypass Grafting for Coronary Arteritis Induced by Myeloproliferative Neoplasms:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
ReviewMomelotinib for the treatment of myelofibrosis in patients with moderate-to-severe anemia: a drug safety evaluation.Expert opinion on drug safety
Review[Clinical presentation, diagnosis, prognosis, and risk-adapted treatment of chronic BCR::ABL1-negative myeloproliferative neoplasms].Innere Medizin (Heidelberg, Germany)
Not labelled yetHigh prevalence and immunophenotypic diversity of clonal T‑large granular lymphocytes in JAK2‑mutated myeloproliferative neoplasms.Annals of hematology
Case reportIsolated add(12)(p13) in a BCR::ABL1-Negative Neutrophilic Myeloproliferative Neoplasm Lacking Canonical Driver Mutations: A Case Report.Cureus
Not labelled yetQRISK3 Assessment Identified Essential Thrombocythemia Patients at High Risk of Thrombotic Events Regardless of Revised IPSET-T Score and JAK2 Mutational Status.EJHaem
ReviewAdvances in Myeloproliferative Neoplasms by single-cell omics studies.Experimental hematology
ReviewRusfertide for the treatment of polycythemia vera.Expert opinion on pharmacotherapy
ReviewRopeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment.Expert review of hematology
Not labelled yetSystemic inflammation response index and total cholesterol in relation to the occurrence of major adverse cardiovascular and cerebrovascular events in patients with myeloproliferative neoplasms.BMC cardiovascular disorders
Not labelled yetClinical risk features and genetic findings in essential thrombocythemia and polycythemia vera of childhood and adolescence: prospective insights from the German MPN Childhood Registry.Haematologica
Case reportSubclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib.American journal of clinical pathology
Case reportMasked Triple-Negative Polycythemia Vera Initially Presenting as Iron Deficiency and Pernicious Anemia.Cureus
Case reportNTRK1-Rearranged Cutaneous Non-Langerhans Cell Histiocytosis With Durable Response to TRK Inhibitor in a Patient With Primary Myelofibrosis.Journal of cutaneous pathology